Management of Intractable Symptoms in Oncologic Care
| Autor: | Ross H. Albert, Katie L. Dziedzic |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Nausea business.industry medicine.medical_treatment Psychological intervention medicine.disease Gastrostomy Bowel obstruction 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Oncology Refractory 030220 oncology & carcinogenesis medicine Vomiting Intractable pain medicine.symptom Intensive care medicine Cancer pain business |
| Zdroj: | Current Oncology Reports. 23 |
| ISSN: | 1534-6269 1523-3790 |
| DOI: | 10.1007/s11912-021-01082-2 |
| Popis: | For patients undergoing evaluation and treatment of cancers, symptom management is a critical component of their treatment plan. For some patients, symptoms may become intractable or refractory to common therapies. Here, we review treatment options for these severe symptom conditions. Medication options and regimens have improved to treat refractory symptoms. Medications can be tailored to treat chemotherapy-induced nausea and vomiting based on current guidelines. Interventions such as venting gastrostomy can mitigate symptoms associated with malignant bowel obstruction, when life expectancy is long enough to realize this benefit. Opiates can reduce refractory dyspnea, consistent with guidelines from the American Thoracic Society. Interventional therapies for intractable pain, such as neurolytic blocks and intrathecal pumps, have shown promise in managing symptoms when traditional therapies have been ineffective. Refractory symptoms can be managed in cancer care. The use of multimodal therapies delivered by interdisciplinary teams appears to be the most effective way to approach these clinical situations. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink